Arovella Therapeutics Limited (ASX:ALA) Secures $20M Placement
Arovella Therapeutics (ASX:ALA) announces a $20 million placement to fund Phase 1 clinical trials and solid tumour pipeline expansion.
Radiopharm Theranostics Limited (ASX:RAD) Raises A$8 Million
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
DigitalX Limited (ASX:DCC) Treasure and Fund Update for December 2024
DigitalX Limited (ASX:DCC) announces significant treasury holdings and performance insights for December 2024.
AdAlta Limited (ASX:1AD) to Present at Biotech Showcase 2025
AdAlta Limited (ASX:1AD) to present its advancements in cell therapeutics at Biotech Showcase 2025 during JPMorgan Healthcare Week.
Unibail-Rodamco-Westfield (ASX:URW) Sells 25% Stake in Centrum Černý Most
URW has sold a 25% stake in Centrum Černý Most, reducing net debt and establishing a partnership for future growth.
Bailador Technology Investments Limited (ASX:BTI) Increases Portfolio Valuations
Bailador Technology Investments Limited announces increased valuations for Updoc and Mosh, reflecting strong business performance.
Belararox Limited (ASX: BRX) Provides Drilling Progress Update
Belararox Limited (ASX: BRX) updates its drilling plans at Malambo and Tambo South, focusing on safety and project timelines.
Briscoe Group Limited (ASX:BGP) Trading Update and NPAT Guidance
Briscoe Group Limited updates on trading performance and adjusts NPAT guidance amidst ongoing retail challenges.
Merchant House International Limited (ASX:MHI) Receives Settlement Funds
Merchant House International Limited receives US$4.9 million from the sale of its 33.79% interest in Tianxing.
VRX Silica Limited (ASX:VRX) EPA Recommends Arrowsmith North Development
VRX Silica Limited receives a key EPA recommendation for the Arrowsmith North development project, marking a critical step in the environmental approval process.